U.S. Markets close in 44 mins

Gilead teams with startup to turn machine learning on fatty liver disease

Ron Leuty
Gilead teams with startup to turn machine learning on fatty liver disease

Aiming to generate fresh data to run through its machine learning system, a startup is embarking on a three-year collaboration with one of biotech's biggest players in the fatty liver disease known as NASH.